Anchiano Therapeutics Ltd (ANCN) and Akari Therapeutics Plc (NASDAQ:AKTX) Comparing side by side
As Biotechnology companies, Anchiano Therapeutics Ltd (NASDAQ:ANCN) and Akari Therapeutics Plc (NASDAQ:AKTX) are our subject to contrast. And more specifically their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.
Valuation and Earnings
Earnings Per Share
Anchiano Therapeutics Ltd
Akari Therapeutics Plc
Table 1 highlights Anchiano Therapeutics Ltd and Akari Therapeutics Plc’s gross revenue, earnings per share and valuation.
Table 2 demonstrates the return on assets, return on equity and net margins of Anchiano Therapeutics Ltd and Akari Therapeutics Plc.
Return on Equity